147 related articles for article (PubMed ID: 21368239)
1. Suppression of cytochrome P450 reductase (POR) expression in hepatoma cells replicates the hepatic lipidosis observed in hepatic POR-null mice.
Porter TD; Banerjee S; Stolarczyk EI; Zou L
Drug Metab Dispos; 2011 Jun; 39(6):966-73. PubMed ID: 21368239
[TBL] [Abstract][Full Text] [Related]
2. The disruption of hepatic cytochrome p450 reductase alters mouse lipid metabolism.
Mutch DM; Klocke B; Morrison P; Murray CA; Henderson CJ; Seifert M; Williamson G
J Proteome Res; 2007 Oct; 6(10):3976-84. PubMed ID: 17722906
[TBL] [Abstract][Full Text] [Related]
3. Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.
Wang XJ; Chamberlain M; Vassieva O; Henderson CJ; Wolf CR
Biochem J; 2005 Jun; 388(Pt 3):857-67. PubMed ID: 15717863
[TBL] [Abstract][Full Text] [Related]
4. NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology.
Riddick DS; Ding X; Wolf CR; Porter TD; Pandey AV; Zhang QY; Gu J; Finn RD; Ronseaux S; McLaughlin LA; Henderson CJ; Zou L; Flück CE
Drug Metab Dispos; 2013 Jan; 41(1):12-23. PubMed ID: 23086197
[TBL] [Abstract][Full Text] [Related]
5. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase.
Gu J; Weng Y; Zhang QY; Cui H; Behr M; Wu L; Yang W; Zhang L; Ding X
J Biol Chem; 2003 Jul; 278(28):25895-901. PubMed ID: 12697746
[TBL] [Abstract][Full Text] [Related]
6. Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype.
Weng Y; DiRusso CC; Reilly AA; Black PN; Ding X
J Biol Chem; 2005 Sep; 280(36):31686-98. PubMed ID: 16006652
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase.
Henderson CJ; Otto DM; Carrie D; Magnuson MA; McLaren AW; Rosewell I; Wolf CR
J Biol Chem; 2003 Apr; 278(15):13480-6. PubMed ID: 12566435
[TBL] [Abstract][Full Text] [Related]
8. Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway.
Finn RD; Henderson CJ; Scott CL; Wolf CR
Biochem J; 2009 Jan; 417(1):43-54. PubMed ID: 18778245
[TBL] [Abstract][Full Text] [Related]
9. P450 oxidoreductase expressed in rat chondrocytes modulates chondrogenesis via cholesterol- and Indian Hedgehog-dependent mechanisms.
Aguilar A; Wu S; De Luca F
Endocrinology; 2009 Jun; 150(6):2732-9. PubMed ID: 19264869
[TBL] [Abstract][Full Text] [Related]
10. Effect of hepatic cytochrome P450 (P450) oxidoreductase deficiency on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adduct formation in P450 reductase conditional null mice.
Arlt VM; Singh R; Stiborová M; Gamboa da Costa G; Frei E; Evans JD; Farmer PB; Wolf CR; Henderson CJ; Phillips DH
Drug Metab Dispos; 2011 Dec; 39(12):2169-73. PubMed ID: 21940903
[TBL] [Abstract][Full Text] [Related]
11. RNA-interference approach to study functions of NADPH : cytochrome P450 oxidoreductase in human hepatocytes.
Feidt DM; Klein K; Nüssler A; Zanger UM
Chem Biodivers; 2009 Nov; 6(11):2084-91. PubMed ID: 19937842
[TBL] [Abstract][Full Text] [Related]
12. Hepatic cytochrome P450 reductase-null mice reveal a second microsomal reductase for squalene monooxygenase.
Li L; Porter TD
Arch Biochem Biophys; 2007 May; 461(1):76-84. PubMed ID: 17374357
[TBL] [Abstract][Full Text] [Related]
13. H-rev107 Regulates Cytochrome P450 Reductase Activity and Increases Lipid Accumulation.
Tsai FM; Chen ML; Wang LK; Lee MC
PLoS One; 2015; 10(9):e0138586. PubMed ID: 26381418
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of NADPH - cytochrome P450 oxidoreductase induction by dexamethasone in the H4IIE rat hepatoma cell line.
Riddick DS; Mullen Grey AK
Can J Physiol Pharmacol; 2020 May; 98(5):267-274. PubMed ID: 31825663
[TBL] [Abstract][Full Text] [Related]
15. Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model.
Levová K; Moserová M; Kotrbová V; Sulc M; Henderson CJ; Wolf CR; Phillips DH; Frei E; Schmeiser HH; Mares J; Arlt VM; Stiborová M
Toxicol Sci; 2011 May; 121(1):43-56. PubMed ID: 21362632
[TBL] [Abstract][Full Text] [Related]
16. 7-Dehydrocholesterol reductase activity is independent of cytochrome P450 reductase.
Zou L; Li L; Porter TD
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):435-8. PubMed ID: 21762780
[TBL] [Abstract][Full Text] [Related]
17. Regulation of intestinal cytochrome P450 expression by hepatic cytochrome P450: possible involvement of fibroblast growth factor 15 and impact on systemic drug exposure.
Zhu Y; Ding X; Fang C; Zhang QY
Mol Pharmacol; 2014 Jan; 85(1):139-47. PubMed ID: 24184963
[TBL] [Abstract][Full Text] [Related]
18. The role of cytochrome P450-dependent metabolism in the regulation of mouse hepatic growth hormone signaling components and target genes by 3-methylcholanthrene.
Lee C; Ding X; Riddick DS
Drug Metab Dispos; 2013 Feb; 41(2):457-65. PubMed ID: 23169610
[TBL] [Abstract][Full Text] [Related]
19. Effects of Diminished NADPH:cytochrome P450 Reductase in Human Hepatocytes on Lipid and Bile Acid Homeostasis.
Heintze T; Wilhelm D; Schmidlin T; Hofmann U; Zanger UM; Schwab M; Klein K
Front Pharmacol; 2021; 12():769703. PubMed ID: 34867397
[TBL] [Abstract][Full Text] [Related]
20. Conditional deletion of cytochrome P450 oxidoreductase in the liver and gastrointestinal tract: a new model for studying the functions of the P450 system.
Finn RD; McLaren AW; Carrie D; Henderson CJ; Wolf CR
J Pharmacol Exp Ther; 2007 Jul; 322(1):40-7. PubMed ID: 17435107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
